Introduction
The estimated ratio of patients referred for renal transplantation due to end-stage renal disease in Brazil is 383/1 million, and the numbers are increasing by 9.9% each year. Renal ischemia in donors during the replacement operation is a major cause of acute renal failure 1 .
Renal ischemia-reperfusion (I-R) also occurs during several other procedures, particularly renal artery revascularization, suprarenal aortic aneurysm correction and partial nephrectomy, and also during laparoscopic procedures 2, 3 .
Reperfusion is crucial for the survival of the ischemic tissue. However, it leads to the release and circulation of various species that may cause additional cell damage 4 . I-R of an organ or tissue results in cell damage via a complex cascade of events that affect the structure and function of all cell organelles 4 . Free radicals, prominent mediators of this cell damage, are produced when the oxygen supply is restored through reperfusion 4 . The alterations most commonly seen in these situations are the formation of reactive oxygen species (ROS), depletion of adenosine 5'-triphosphate (ATP), neutrophil infiltration, phospholipase activation and damage to the cell membrane 4 .
Ingestion of specific nutrients can modulate the inflammatory response in several organs, thus lowering the damaging force of the physiologic cascade of events 5 . It has been demonstrated that the administration of neutral amino acids, such as glycine and alanine, prevents damage to renal tubule cells from ischemia or hypoxemia 5 .
Glutamine (GLN) is the most abundant amino acid found in the bloodstream, and its presence is thought to be essential in the setting of a critical condition 6 . One of its most significant characteristics is to be a precursor of glutathione (GSH), which is considered to be a potent antioxidant agent 7 . It is common knowledge that when the kidneys are submitted to oxidant stress, GLN is the limiting factor for GSH synthesis 7 .
Fuller et al. 6 reported that GLN administered during the pretreatment of rats undergoing kidney transplantation attenuated tubular cell apoptosis. Mora et al. 7 noted partial protection from cisplatin-induced nephrotoxicity in rats treated with GLN. In addition, GLN is known to protect the liver from the effects of post-I-R injury.
In this context, it is most likely that GLN supplementation for 7 days before renal I-R raises the organic antioxidant capacity, with a consequent decrease in renal injury. The scarcity of reports in the literature from studies specifically investigating this has motivated the present research.
The aim of this study was to evaluate the effects of GLN supplementation on the plasma antioxidant system, by assessing:
(1) total antioxidant capacity (TAC); (2) glutathione peroxidase; Automated biochemical determination of LDH, urea and creatinine levels, TAC, and glutathione peroxidase and SOD levels was performed at Santa Rosa Laboratory (Cuiaba-MT, Brazil), using kits from Randox Laboratories Ltd. All the determinations were made on the same day that the material was collected.
Histological changes were classified using the criteria established by Chander et al. 9 for renal injuries, and Greca et al. 10 for lung lesions.
Statistical analysis was performed using SPSS for The histological study showed fewer morphologic changes in the sham group than in the control and GLN groups.
The control and GLN groups, however, had quite similar degrees of histological damage and there was no statistically significant difference between them (Figure 4) . Eschwége et al. 21 have demonstrated that a period of renal ischemia longer than 45 minutes causes changes in urea and creatinine levels, with significant elevation after 48 hours of reperfusion and a trend towards normalization after the tenth day.
Paller et al. 22 , in a classic study, observed lower creatinine levels in rats in which SOD had been administered before 1 hour of renal ischemia followed by reperfusion for 15 minutes than in rats that had not received SOD. Such differences were more striking in samples collected after 24 hours of ischemia.
Tucci et al. 23 demonstrated protection with chlorpromazine administration when renal ischemia was applied for 1 hour; however, urea and creatinine levels rose after 24 hours of reperfusion.
In the present study no difference in urea and creatinine results was observed among the groups. This finding may be related to the reperfusion period, which was only 60 minutes.
Additionally, compensatory renal hypertrophy, a phenomenon already well established in the literature may have occurred 24 .
In our study, renal ischemia was related to a significant increase in LDH in the GLN and control groups when compared with the sham group. Although GLN had a protective effect, this did not reach statistical significance. This has also been observed in other studies on oxidative stress, in which the benefit from using
Effect of glutamine on the total antioxidant system of rats subjected to renal ischemia and reperfusion GLN could not be proven 15 .
Acidosis (one of the main components of I-R syndrome)
was indirectly demonstrated by the greater rise in LDH values in the control group. In the literature we found an association of acidosis with hyperkalemia, myoglobinemia, myoglobinuria, acute renal failure, non-cardiogenic pulmonary edema and alterations of the pressor response, all of which resulted in multiple organ dysfunction and death 25 . In this study these other systemic parameters of I-R syndrome were not assessed; therefore, there is only a suggestion that other organs may have been involved in the resulting damage. Similarly, there is a suggestion that GLN, acting at the cellular level, might have acted as a protective factor.
In our study, we found similar glutathione peroxidase values in the sham and GLN groups; the control group had significantly lower levels. These results indicate that animals that received GLN supplementation had higher GSH reserves, as levels were maintained despite the predicted expenditure in terms of tamponade oxidative radicals generated by renal I-R. This finding seems to corroborate the beneficial effect of GLN as a cellprotective agent in I-R.
This effect was also observed by Ezhilan et al. 12 in myocardial cells subjected to oxidative injury. Their conclusion was that elevation of total GSH and glutathione peroxidase levels was due to previous treatment with GLN 12 . Abilés et al. 13 demonstrated an increase in glutathione peroxidase when supplementing patients with severe disease with GSH, and this increase was proportional to the elevation of GSH; they also found an inverse relationship between levels of this enzyme and lipid peroxidation in these patients. A similar result was reported by Kul et al. 14 , who used enteral GLN in animal models, with elevation in glutathione peroxidase levels and a decrease in lipid peroxidation in the bowel.
In the model used in this study, GLN was shown to preserve total plasma antioxidant capacity. Such an effect has already been demonstrated by other authors such as Bicudo et al. 15 and Szijártó et al. 16 in animal models of hepatic I-R. This may be related either to a rise in plasma antioxidant components, with -once again -GSH prominent, or to an inhibitory action on ROS production, consequently decreasing the organic demand for
antioxidants. An interesting observation was that TAC values were similar in the GLN and control groups. This might be explained by albumin also having an antioxidant capacity, as reported by other investigators 17, 18 .
SOD activity was reduced in the GLN and control groups in comparison with the sham group. This behavior is compatible with results from Ezhilan et al. 12 Additionally, Jia et al. 19 did not observe elevated SOD levels after hepatic I-R in rats that had received GLN prior to an I-R event.
Ahmet, apud Kahraman 20 suggests that SOD is inactivated by high levels of oxygen radicals, their amounts decreasing after I-R. Alternatively, there may have been high expenditure of this enzyme during the reperfusion phase. This is a possibility, as SOD is a key antioxidant enzyme that neutralizes the superoxide radical, a molecular precursor of all other ROS and their derivatives.
Kramer et al. 26 highlighted the increase in pulmonary vascular permeability after renal I-R. This occurred after only 1 hour of renal reperfusion, with a peak occurring at 48 hours of reperfusion, and the effect disappearing after 96 hours.
Deng et al. 27 detected evidence of alterations in pulmonary histology after 4 hours of renal reperfusion. These comprised edema in the interstitial spaces, increases in interstitial cellularity and inflammation of the alveolar space.
In our study the pulmonary and renal histological changes were of discrete intensity, both in the GLN and control groups, and were substantially less intense in the sham group. This justifies with the fact that reperfusion was not extended for a longer period of time. Eventually, in the histological study a longer reperfusion could determine the same benefit seen in the systemic antioxidant activity with ingestion of this amino acid.
In conclusion, this study using GLN proposes a novel approach that may ultimately benefit patients undergoing surgical procedures involving renal I-R, as well as those undergoing renal transplantation. We must pay attention to the fact that recent studies propose ischemic preconditioning in organs to be subjected to I-R stress. Such preconditioning requires induction with a short period of ischemia followed by a short reperfusion period, before the longer ischemia occurs. The role of ischemic preconditioning in an enhanced tolerance to ischemia has been reported for several organs, such as the heart, brain, spinal cord, skeletal muscle, retina, kidneys, bowel and the liver. However, despite the relative abundance of studies on the protective effects of ischemic preconditioning, the physiological foundations of this approach have not yet been clearly established 28 .
Conclusion
The administration of glutamine prior to a renal ischemiareperfusion improved the antioxidant system, as it was associated with preservation of total antioxidant capacity and elevation of glutathione peroxidase, even in the absence of improvement in other study variables, including kidney and pulmonary histology.
